AGP Executive Report
Last update: an hour agoPharma Deal: SERB Pharmaceuticals is buying European and MENA rights to Idefirix® (imlifidase) from Hansa Biopharma for €115 million, aiming to expand access for highly sensitised kidney-transplant patients who face long or indefinite waits. Regulatory Push: At a Norway visit, Indian PM Narendra Modi heard from Norwegian firms that “ground level” hurdles and slow approvals are holding back business, with calls to streamline regulatory frameworks. Green Partnership: Modi and Norway’s Jonas Gahr Støre unveiled a “Green Strategic Partnership” spanning clean energy, climate resilience, the blue economy and green shipping, alongside plans to grow trade. Health Policy in Europe: The EU approved expanded use of Pfizer’s HYMPAVZI for inhibitor patients aged 12+ (once-weekly subcutaneous), widening options for a hard-to-treat group. Cross-border Compliance: UK travel rules are in focus again—airports warn that bringing meat/dairy sandwiches into Great Britain can trigger fines if not declared.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
